Mission & Vision
At CardioAssure™, we aim to advance remote cardiac care by intelligently monitoring implantable cardiac devices (CIEDs) in real time. We envision a future where continuous, cloud-connected diagnostics empower providers to deliver safer, more efficient, and more personalized care, especially for older patients at higher risk from in-person clinical visits.
Our Story
CardioAssure™ was founded during the COVID-19 pandemic, when two technologists came together to address emerging challenges in healthcare access and continuity of care. The pandemic underscored a critical need: patients with implanted cardiac devices—pacemakers, ICDs, and CRTs—required continuous oversight, yet were especially vulnerable to disruptions in follow-up and in-person evaluations.
Driven by this unmet need, the founders developed a secure, edge-to-cloud platform that delivers actionable insights into physiologic trends and device diagnostics. With guidance from seasoned healthcare advisors, the team built a solution tailored to the unique needs of the CIED population, supporting earlier intervention, better outcomes, and reduced reliance on physical clinics.
Intellectual Property
CardioAssure™ is proud to be protected by U.S. intellectual property. We were recently issued a U.S. patent for innovations supporting real-time, secure data transmission from implantable cardiac devices to care teams.